Management of Sertraline-Induced Extrapyramidal Symptoms

Immediate Management

The American Academy of Child and Adolescent Psychiatry recommends documenting baseline abnormal movements using the Abnormal Involuntary Movement Scale before initiating treatment for sertraline-induced extrapyramidal symptoms 1, 2
Anticholinergic agents, such as benztropine 1-2 mg IM/IV or diphenhydramine 25-50 mg IM/IV, are effective for acute dystonic reactions and should be administered promptly 1, 2
For persistent akathisia, consider propranolol 10-20 mg TID or benzodiazepines, as antiparkinsonian agents are inconsistently helpful 1, 2

The American Academy of Family Physicians suggests considering fluoxetine or citalopram as alternative SSRIs if depression treatment must continue, while avoiding paroxetine due to higher discontinuation syndrome risk and increased association with movement disorders 3
Citalopram requires caution at doses >40 mg/day due to QT prolongation risk, according to Praxis Medical Insights 3
Non-serotonergic alternatives, such as bupropion or mirtazapine, can be selected to avoid recurrence of extrapyramidal symptoms if depression requires ongoing treatment 4

The American Academy of Child and Adolescent Psychiatry recommends reassessing every 3-6 months for any persistent movement abnormalities if antipsychotic or SSRI therapy is reintroduced 1, 2
It is essential to document that sertraline caused extrapyramidal symptoms in the medical record to prevent future re-challenge, and to rule out serotonin syndrome by checking for additional symptoms, including hyperthermia, rigidity, autonomic instability, and altered mental status 3